These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1321 related items for PubMed ID: 29195777

  • 1. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
    Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ.
    Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
    Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.
    Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725
    [Abstract] [Full Text] [Related]

  • 4. Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.
    Campbell SR, Tom MC, Agrawal S, Efstathiou JA, Michalski JM, Abramowitz MC, Pollack A, Spratt DE, Hearn JWD, Stephans KL, Gao T, Li J, Tendulkar RD.
    Eur Urol Oncol; 2022 Jun; 5(3):304-313. PubMed ID: 34016556
    [Abstract] [Full Text] [Related]

  • 5. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A.
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [Abstract] [Full Text] [Related]

  • 6. Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram.
    Meijer HJ, Debats OA, Roach M, Span PN, Witjes JA, Kaanders JH, van Lin EN, Barentsz JO.
    Int J Radiat Oncol Biol Phys; 2012 Dec 01; 84(5):1186-91. PubMed ID: 22520482
    [Abstract] [Full Text] [Related]

  • 7. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J, Even-Sapir E, Ben-Haim S, Saad A, Spieler B, Davidson T, Berger R, Weiss I, Appel S, Lawrence YR, Symon Z.
    Am J Clin Oncol; 2017 Jun 01; 40(3):256-259. PubMed ID: 25319322
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
    Couñago F, Recio M, Maldonado A, Del Cerro E, Díaz-Gavela AA, Thuissard IJ, Sanz-Rosa D, Marcos FJ, Olaciregui K, Mateo M, Cerezo L.
    Cancer Imaging; 2016 Dec 07; 16(1):42. PubMed ID: 27927229
    [Abstract] [Full Text] [Related]

  • 9. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.
    Eur Urol; 2018 Apr 07; 73(4):512-518. PubMed ID: 29229176
    [Abstract] [Full Text] [Related]

  • 10. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun 07; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 11. The impact of a negative (111)indium-capromab pendetide scan before salvage radiotherapy.
    Proaño JM, Sodee DB, Resnick MI, Einstein DB.
    J Urol; 2006 May 07; 175(5):1668-72. PubMed ID: 16600726
    [Abstract] [Full Text] [Related]

  • 12. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N, Karnes RJ, Cozzarini C, Fiorino C, Gandaglia G, Joniau S, Boorjian SA, Goldner G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T, Briganti A.
    Eur Urol; 2016 Apr 07; 69(4):728-733. PubMed ID: 26497924
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: validation of the Stephenson nomogram.
    Hugen CM, Polcari AJ, Quek ML, Garza RP, Fitzgerald MP, Flanigan RC.
    World J Urol; 2010 Dec 07; 28(6):741-4. PubMed ID: 20449749
    [Abstract] [Full Text] [Related]

  • 14. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 15. Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.
    von Hardenberg J, Cash H, Koch D, Borkowetz A, Bruendl J, Leyh-Bannurah SR, Kuru TH, Kowalewski KF, Schindele D, Mala KS, Westhoff N, Blana A, Schostak M, Working Group of Focal and Microtherapy of the German Society of Urology (DGU).
    World J Urol; 2021 Oct 01; 39(10):3747-3754. PubMed ID: 33881557
    [Abstract] [Full Text] [Related]

  • 16. The use of 68  Ga-PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer.
    Meredith G, Wong D, Yaxley J, Coughlin G, Thompson L, Kua B, Gianduzzo T.
    BJU Int; 2016 Oct 01; 118 Suppl 3():49-55. PubMed ID: 27659411
    [Abstract] [Full Text] [Related]

  • 17. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K, Eineluoto JT, Pohjonen J, Erickson A, Kilpeläinen TP, Järvinen P, Santti H, Petas A, Matikainen M, Marjasuo S, Kenttämies A, Mirtti T, Rannikko A.
    PLoS One; 2020 Oct 01; 15(7):e0235779. PubMed ID: 32645056
    [Abstract] [Full Text] [Related]

  • 18. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
    Lohm G, Neumann K, Budach V, Wiegel T, Hoecht S, Gollrad J.
    Strahlenther Onkol; 2018 Apr 01; 194(4):325-332. PubMed ID: 29255924
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.
    Urology; 2004 Oct 01; 64(4):760-4. PubMed ID: 15491716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.